Mesothelioma is a malignant tumor originating from the membranes surrounding the lung, heart and abdominal organs. This tumor, most often caused by asbestos, is most commonly seen in the pleura, the membrane surrounding the lung. The tumor can cause death within a few months if left untreated. The most important known risk factor for mesothelioma is asbestos. Inhaled asbestos adheres to the lung membrane due to its fibrous structure, causing mesothelioma commercial. Patients suffer from back, chest and lateral pain due to the accumulation of fluid in the lung membrane. The pain is initially stinging with breathing, then gradually increases in severity and shows continuity. Shortness of breath may occur in the patient. Cough is also seen.
Physical examination of the patient revealed decreased breathing sounds on the patient’s side and a slightly smaller chest side with a lower shoulder position. Chest X-ray and computed tomography showed fluid accumulation in the pleural cavity and the lung membrane was thickened.
Then, some liquid is taken from the patient with an injector and examined. Although tumor cells may be seen in the fluid, a biopsy is required for definitive diagnosis. Biopsy; closed pleural biopsy, open pleural biopsy or thoracoscopic methods. The most successful method to diagnose the disease is a thoracoscopic examination of the pleura and extensive biopsy.
How is mesothelioma commercial treated?
There are three types of mesothelioma: epithelial, sarcomatous and mixed. Despite years of studies, there is no standardized treatment of mesothelioma. It is currently known and accepted that selected patients receive multidisciplinary treatment (combined with surgery, radiotherapy, and chemotherapy), which can achieve an average chance of success of 40% per year. Especially in epithelial type mesothelioma, surgical treatment combined with chemotherapy and radiotherapy increases the success of treatment. The aim of surgical treatment of the disease is to remove the diseased lung tissue as much as possible. In cases where the disease also spreads to the membrane of the heart and the diaphragm, it is recommended to remove these affected organs and replace them with patches.
Mesothelioma, originating from mesothelial cells, pleura, peritoneum
It is a primary tumor of the mesothelial dressing covering the pericardium. Malignant pleural mesothelioma (MPM) is a rare clinically aggressive disorder for normal population and fatal course. Every year due to malignant pleural mesothelioma 2000-3000 people die in the USA. Professional asbestos more often in men due to risk increases with the increase (1-2-3). Mesothelioma histologically three epithelial tumors are the most common type and the prognosis is biphasic.
sarcomatoid tumors. Major risk factor for MPM exposure to asbestos and often occurs 20-60 years after exposure (3-4-5). The diagnosis in MPM is based on cytological and histopathological examination (6-7). But this diagnosis rate is about 40% (8). MPM is rapidly spreading all over the world, which is the treatment of mesothelioma. efforts have increased significantly in recent years. Still a standard surgery, chemotherapy in malign pleural mesothelioma commercial without treatment radiotherapy is used alone or in combination. Today, combined with surgical treatment chemotherapy and radiotherapy the overall survival rate was selected in the studies. This combination may be useful in a group of patients. MPM does not respond adequately to treatment practices. the original structure of the disease and the new treatment of this disease application. For this purpose, photodynamic therapy, gene therapy New studies such as.
The aim of this study was to evaluate the general population of patients with MPM. evaluate survival times and be effective in overall survival to determine the factors.